Results 131 to 140 of about 2,559,828 (152)

Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy. [PDF]

PLoS One, 2017
Jadot I, Colombaro V, Martin B, Habsch I, Botton O, Nortier J, Declèves AE, Caron N.   +7 more
europepmc   +1 more source

Cancer Incidence and Outcomes After Kidney Transplantation in Balkan Nephropathy Patients. [PDF]

J Clin Med
Prtorić M, Atić A, Jelaković B, Kaštelan Ž, Bašić-Jukić N.   +4 more
europepmc   +1 more source

Smad7 protects against chronic aristolochic acid nephropathy in mice. [PDF]

Oncotarget, 2015
Dai XY, Zhou L, Huang XR, Fu P, Lan HY.
europepmc   +1 more source

Pharmacologic disruption of HuR-RNA interactions prevents maladaptive tubular repair and AKI-to-CKD progression. [PDF]

Am J Physiol Renal Physiol
Wang Z, Liu S, Zhuang L, Qiu Y, Aube J, Wu X, Xu L, Huang Y.   +7 more
europepmc   +1 more source

A dual role of AcSDKP in chronic kidney disease: Targeting pericyte-driven fibrosis and vascular repair via VEGF/FGFR1 while eliciting a compensatory FGFR1 upregulation in apoptotic tubular cells. [PDF]

PLoS One
Zhu S, Shi L, Huang L, Cui N, Chen R, Jiang L, Zhang A, Xu Y, Li X.   +8 more
europepmc   +1 more source

Mitochondrial DNA Damage Induced by Aristolochic Acid I: Recognizing the Heart as a Target Organ. [PDF]

Chem Res Toxicol
Kwok HC, Cheng KH, Chan W.
europepmc   +1 more source

Integrating machine learning, deep learning, and docking to predict aristolochic acid A carcinogenesis. [PDF]

Front Pharmacol
Li L, Liao J, Chen X, Lin Z, Gong S, Huang J, Bi Z, Wang T, Chia X, Chen L, Xu Y, Liu H, Hao J, Qi J.   +13 more
europepmc   +1 more source

Aristolochic Acid and Hepatocellular Carcinoma: A Critical Review of Genotoxic and Inflammatory Mechanisms. [PDF]

Int J Mol Sci
Wang Y, Zhang Y, Ren T, Yuan L, Geng X.
europepmc   +1 more source

Aristolochic Acid Nephropathy: The Hong Kong Perspective [PDF]

Hong Kong Journal of Nephrology, 2007
Aristolochic acid nephropathy (AAN) is a progressive tubulointerstitial nephropathy attributed to aristolochic acid (AA) toxicity. Five cases of AAN have been diagnosed in Hong Kong.
Wing Tat Poon
exaly   +2 more sources

Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy [PDF]

Kidney International, 2012
Experimental aristolochic acid nephropathy is characterized by early tubulointerstitial injury followed by fibrosis, reproducing chronic lesions seen in humans.
Joelle Nortier, Volker Manfred Arlt, Marie-Helene Antoine   +2 more
exaly   +2 more sources